Cite
HARVARD Citation
Izumi, K. et al. (2015). Tocilizumab is clinically, functionally, and radiographically effective and safe either with or without low-dose methotrexate in active rheumatoid arthritis patients with inadequate responses to DMARDs and/or TNF inhibitors: A single-center retrospective cohort study (KEIO-TCZ study) at week 52. Modern rheumatology. 25 (1), pp. 31-37. [Online].